Searched for
ASTRAZENECA SHARE FALL
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- US pharma stocks gain up to 5% on Trump's move to slash drug pricesPresident Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries, setting pric...
- GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 mln pounds in 2023GSK CEO Emma Walmsley's total remuneration rose 51% to 12.7 million pounds ($16 million) in 2023, driven by a significant increase in perfo...
- AstraZeneca starts to make modest profit from Covid-19 vaccineThe Anglo-Swedish company's third-quarter results showed the vaccine contributed one cent to core earnings per share of $1.08, a rise of 14...
- AstraZeneca Pharma gains despite fall in Q2 profit; here's whyIn the July-September quarter, AstraZeneca Pharma India reported a decline of 54.65 per cent in net profit to Rs 11.94 crore. In the same p...
- Joe Biden outlines vaccine plan, set to miss global-sharing goalThe White House announced the final allocations for the doses, with 60 million shots going to the global COVAX vaccine sharing alliance and...
- US recommends 'pause' for J&J vaccine over clot reportsIn a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigat...
- Australia shares slip after government scraps vaccination targetsThe S&P/ASX 200 index slipped 0.3 per cent to 6,974, closing lower for the second straight session. Last week, it had posted its best weekl...
- Countries call on drug companies to share vaccine know-howIt is one of three factories that The Associated Press found on three continents whose owners say they could start producing hundreds of mi...
- Stocks in the news: Voda Idea, Nestle, Wipro, SIS, Varun Beverages and Parsvnath DevelopersFuture Group has alleged that Amazon had asked for $40 million (around Rs 290.41 crore) in compensation for the deal with Reliance Industri...
- Gold steadies as vaccine doubts weigh on recovery outlookGold was down over 3% for the week as progress in COVID-19 vaccine development and U.S. President-elect Joe Biden's transition to the White...
- Vaccine hopes lift Sensex 290 points; mid, smallcaps rally post Sebi's moveIn the 30-share pack Sensex, HCL Tech was the biggest gainer, followed by Tech Mahindra, TCS, Reliance Industries, Infosys and HDFC.
- European shares rise; AstraZeneca drops after halting vaccine trialsThe pan-European STOXX 600 index rose 0.8%, with sub-indexes of sectors hit most by the pandemic lagging. Travel and leisure stocks fell 1....
- AstraZeneca approaches Gilead about potential mergerAstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc. about a potential merger.
- Shilpa Medicare zooms on receiving GMP certificate from Japan regulatorShilpa Medicare informed BSE that it has received good manufacturing practice (GMP) compliance certificate for two of its Karnataka-based A...
- AstraZeneca shares fall 14 per cent after rejecting Pfizer offerPfizer offer rejected by AstraZeneca, shares plummet by 14 per cent consequently.
- Alfa Laval delisting is eminent: Ganesh Shanbhag, SMS Financial ServicesGanesh Shanbhag, SMS Financial Services, talks to ET Now on the talks of Alfa Laval delisting and what should the share holders do about it...
- Aurobindo Pharma signs supply pact with AstraZenecaAurobindo Pharma said it has entered into an agreement with AstraZeneca to supply solid dosage & sterile products to emerging markets.
- Cholesterol drugmakers brace for competitionThe makers of cholesterol drugs are promoting their products ahead of a major change that is expected to trigger more competition in the ma...
Load More
